|

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

RECRUITINGSponsored by Jonsson Comprehensive Cancer Center
Actively Recruiting
SponsorJonsson Comprehensive Cancer Center
Started2020-02-21
Est. completion2026-02-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04742608

Summary

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged 18 and older
* Consented for thyroid surgery for thyroid cancer or indeterminate thyroid nodule

Exclusion Criteria:

* Patients with concurrent malignancy

Conditions3

CancerThyroid Gland CarcinomaThyroid Gland Nodule

Locations1 site

UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095
James Wu303-518-3186jameswu@mednet.ucla.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.